Jacobs Levy Equity Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,057
| Closed | -$1.18M | – | 956 |
|
|
2024
Q1 | $1.18M | Buy |
20,057
+903
| +5% | +$53.1K | 0.01% | 689 |
|
|
2023
Q4 | $1.15M | Sell |
19,154
-90,354
| -83% | -$5.41M | 0.01% | 693 |
|
|
2023
Q3 | $4.17M | Buy |
+109,508
| New | +$4.17M | 0.02% | 411 |
|
|
2022
Q1 | – | Sell |
-310,594
| Closed | -$14.7M | – | 995 |
|
|
2021
Q4 | $14.7M | Sell |
310,594
-203,047
| -40% | -$9.6M | 0.1% | 237 |
|
|
2021
Q3 | $16.9M | Buy |
513,641
+390,616
| +318% | +$12.9M | 0.11% | 211 |
|
|
2021
Q2 | $7.78M | Sell |
123,025
-138,243
| -53% | -$8.74M | 0.05% | 346 |
|
|
2021
Q1 | $11.2M | Buy |
261,268
+180,887
| +225% | +$7.76M | 0.09% | 269 |
|
|
2020
Q4 | $4.6M | Sell |
80,381
-39,862
| -33% | -$2.28M | 0.04% | 410 |
|
|
2020
Q3 | $3.63M | Buy |
120,243
+40,731
| +51% | +$1.23M | 0.04% | 413 |
|
|
2020
Q2 | $2.6M | Buy |
+79,512
| New | +$2.6M | 0.03% | 471 |
|